Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050284 · ClinicalTrials.gov registry record
Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 158
- Enrollment target
NCT00050284 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 158 participants.
The verdict
NCT00050284 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether patients who have asymptomatic HIV infection can discontinue antiretroviral therapy (ART) without adverse clinical, virologic, or immunologic consequences. This study will also assess the virologic, immunologic, and clinical outcomes in any patients who restart ART.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00050284
The ClinicalTrials.gov registry entry for NCT00050284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00050284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00050284 about?
NCT00050284 is a clinical study titled "Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection". The purpose of this study is to determine whether patients who have asymptomatic HIV infection can discontinue antiretroviral therapy (ART) without adverse clinical, virologic, or immunologic consequences. This study will also assess the virologic, immunologic, and clinical outcomes in any patients ...
What is the current status of trial NCT00050284?
This trial is currently completed. The enrollment target is 158 participants.
Who is sponsoring clinical trial NCT00050284?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.